News

A new study of advancements in immunotherapy for glioma analyzed the 100 most cited papers of the past 20 years and concluded that Duke researchers had made the biggest impact in the field.

World Cancer Day is a day for education and awareness surrounding cancer and its prevention, detection, and treatment.

A groundbreaking clinical trial is taking a new approach to treat seizures: brain cell transplantation.

Ines Batinic-Haberle, PhD, professor emeritus of radiation oncology at Duke University School of Medicine, created hundreds of compounds before she hit upon the right one.

While the risks of drug use, smoking and drinking during pregnancy are widely accepted, a new survey of parents has identified clear associations between certain types of childhood cancers and gestational substance use, notably cannabis.

While laser interstitial thermal therapy (LITT) is increasingly used to treat brain tumors, it is sometimes associated with cerebral swelling and temporarily worsened symptoms.

Gender may be a prognostic factor in survival and clinical outcomes for patients undergoing treatment for spine metastases, a new retrospective review by Duke researchers finds.

A  Duke University team has demonstrated two new strategies that use deep brain stimulation to improve the symptoms of Parkinson’s disease.

In a study out today, Duke researchers describe a newly discovered interaction of two specialized cells in the protective covering of the brain (dura).

Duke researchers have found that offering dual immune-checkpoint inhibition (ICPI) to patients with melanoma or non-small cell lung cancer who are receiving stereotactic radiosurgery (SRS) for brain metastases significantly improves local and intracranial control.